Joint Statement on the Section 56 Exemption for CDSA Drugs
In response to the COVID-19 pandemic, Health Canada issued a section 56 exemption for all drugs under the Controlled Drugs and Substances Act (CDSA) to reduce regulatory barriers to support the continuity of care for patients. The exemption has now been extended until September 30, 2026.  READ MORE